Fosfomycin and Tobramycin in Combination Downregulate Nitrate Reductase GenesnarGandnarH, Resulting in Increased Activity against Pseudomonas aeruginosa under Anaerobic Conditions

Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut

(2013) S. E. Winter et al.   SCIENCE

Genomewide Overexpression Screen for Fosfomycin Resistance in Escherichia coli: MurA Confers Clinical Resistance at Low Fitness Cost

(2012) Alejandro Couce et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa

(2012) David L. MacLeod et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients

(2012) Priyanka Rao et al.   Journal of Cystic Fibrosis

Anaerobic Respiration of Escherichia coli in the Mouse Intestine

(2011) Shari A. Jones et al.   INFECTION AND IMMUNITY

Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions

(2011) Gerard McCaughey et al.   Journal of Cystic Fibrosis

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

(2011) Abdul Ashish et al.   Journal of Cystic Fibrosis

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

(2011) M. M. Tunney et al.   THORAX

Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation

(2010) Marko Petek et al.   BMC MICROBIOLOGY

Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli

(2010) Sho Takahata et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway

(2010) Lucas R. Hoffman et al.   PLoS Pathogens

Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis

(2009) J. E. Foweraker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Contribution of Oxidative Damage to Antimicrobial Lethality

(2009) X. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Compensatory periplasmic nitrate reductase activity supports anaerobic growth of Pseudomonas aeruginosa PAO1 in the absence of membrane nitrate reductase

(2009) Nadine E. Van Alst et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients

(2009) Paula King et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa

(2009) A. Castaneda-Garcia et al.   JOURNAL OF BACTERIOLOGY

Pseudomonas aeruginosa – a phenomenon of bacterial resistance

(2009) Tanya Strateva et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

(2008) Michael M. Tunney et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Identification of a Repressor of a Truncated Denitrification Pathway in Moraxella catarrhalis

(2008) W. Wang et al.   JOURNAL OF BACTERIOLOGY

Proteomic, Microarray, and Signature-Tagged Mutagenesis Analyses of Anaerobic Pseudomonas aeruginosa at pH 6.5, Likely Representing Chronic, Late-Stage Cystic Fibrosis Airway Conditions

(2008) M. D. Platt et al.   JOURNAL OF BACTERIOLOGY

Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression

(2008) Lucas R. Hoffman et al.   Journal of Cystic Fibrosis